Tuberculosis Diagnosis

Novel genetic assay can reduce waiting period

Published in TB and Outbreaks Week, July 2nd, 2002

by Michael Greer, senior medical writer - A novel genetic tuberculosis screen can reduce the time period needed for conclusive diagnosis, researchers in the United States report.

Cathal E. O'Sullivan and colleagues at the National Cancer Institute in Bethesda, Maryland, and the Mayo Clinic and Foundation in Rochester, Minnesota, evaluated the Amplified Mycobacterium Tuberculosis Direct (AMTD) test from San Diego-based Gen-Probe, Inc.

This tuberculosis screen was both highly accurate and significantly faster than conventional diagnostic techniques, O'Sullivan and coauthors found.

The researchers assessed the AMTD assay's ability to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-07-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry